| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $588.9M | -15.7% |
| R&D Expense | $79.0M | -0.8% |
| SG&A Expense | $131.8M | -5.5% |
| Operating Income | $59.3M | — |
| Pre-tax Income | $21.2M | +159.9% |
| Income Tax | $3.0M | -48.9% |
| Net Income | $17.6M | +142.8% |
| EPS (Basic) | $0.10 | +145.5% |
| EPS (Diluted) | $0.10 | +145.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $129.7M | -4.5% |
| Accounts Receivable | $37.0M | -7.7% |
| Current Assets | $212.8M | -2.5% |
| Total Assets | $1.37B | -3.5% |
| Current Liabilities | $100.7M | -9.1% |
| Long-term Debt | $523.4M | -0.9% |
| Total Liabilities | $654.9M | -2.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $111.5M | -1.5% |
| Capital Expenditures | $2.2M | +52.3% |
| Investing Cash Flow | -$30.6M | -148.6% |
| Financing Cash Flow | -$87.6M | -46.9% |
| Free Cash Flow | $109.2M | -2.2% |
| $716.9M |
| -4.5% |